| 000 | 01642 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516020932.0 | ||
| 264 | 0 | _c20110516 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a0379-0355 | ||
| 024 | 7 |
_a10.1358/mf.2010.32.9.1444768 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, X P | |
| 245 | 0 | 0 |
_aProtective effects of ligustrazine, kakonein and Panax notoginsenosides on multiple organs in rats with severe acute pancreatitis. _h[electronic resource] |
| 260 |
_bMethods and findings in experimental and clinical pharmacology _cNov 2010 |
||
| 300 |
_a631-44 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrugs, Chinese Herbal |
| 650 | 0 | 4 |
_aGinsenosides _xpharmacology |
| 650 | 0 | 4 |
_aIsoflavones _xpharmacology |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPanax _xchemistry |
| 650 | 0 | 4 |
_aPancreas _xdrug effects |
| 650 | 0 | 4 |
_aPancreatitis _xcomplications |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSaponins _xpharmacology |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aWang, C | |
| 700 | 1 | _aWu, D J | |
| 700 | 1 | _aMa, M L | |
| 700 | 1 | _aOu, J M | |
| 773 | 0 |
_tMethods and findings in experimental and clinical pharmacology _gvol. 32 _gno. 9 _gp. 631-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1358/mf.2010.32.9.1444768 _zAvailable from publisher's website |
| 999 |
_c20508596 _d20508596 |
||